Cardiotoxicity Induced by Protein Kinase Inhibitors in Patients with Cancer

Kinase inhibitors (KIs) represent a growing class of drugs directed at various protein kinases and used in the treatment of both solid tumors and hematologic malignancies. It is a heterogeneous group of compounds that are widely applied not only in different types of tumors but also in tumors that a...

Descripción completa

Detalles Bibliográficos
Autores principales: Grela-Wojewoda, Aleksandra, Pacholczak-Madej, Renata, Adamczyk, Agnieszka, Korman, Michał, Püsküllüoğlu, Mirosława
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910876/
https://www.ncbi.nlm.nih.gov/pubmed/35269958
http://dx.doi.org/10.3390/ijms23052815

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910876/
https://www.ncbi.nlm.nih.gov/pubmed/35269958
http://dx.doi.org/10.3390/ijms23052815

Ejemplares similares